نتائج البحث - "Satoru Kitazono"

1

Monitoring epidermal growth factor receptor C797S mutation in Japanese non–small cell lung cancer patients with serial cell‐free DNA evaluation using digital droplet PCR

المؤلفون: Yusuke Ono, Ryohei Katayama, Noriko Yanagitani, Ken Uchibori, Makoto Nishio, Satoru Kitazono, Ryo Ariyasu, Ryohei Yoshida, Yusuke Mizukami, Mika Tsukahara, Takaaki Sasaki, Kazuma Kiyotani, Yuichi Ishikawa, Naoya Fujita, Hironori Ninomiya

المصدر: Cancer Science

مصطلحات موضوعية: 0301 basic medicine, Neuroblastoma RAS viral oncogene homolog, Male, Cancer Research, Lung Neoplasms, T790M, Polymerase Chain Reaction, droplet digital PCR, GTP Phosphohydrolases, 0302 clinical medicine, Japan, Carcinoma, Non-Small-Cell Lung, Osimertinib, Digital polymerase chain reaction, Epidermal growth factor receptor, Trametinib, Aniline Compounds, biology, High-Throughput Nucleotide Sequencing, General Medicine, Middle Aged, ErbB Receptors, Oncology, 030220 oncology & carcinogenesis, osimertinib, Cohort, Disease Progression, Original Article, Female, Cell-Free Nucleic Acids, C797S, EGFR, resistance, 03 medical and health sciences, Clinical Research, Cell Line, Tumor, medicine, Humans, Lung cancer, Aged, Acrylamides, business.industry, Membrane Proteins, Original Articles, Sequence Analysis, DNA, medicine.disease, respiratory tract diseases, 030104 developmental biology, Drug Resistance, Neoplasm, Mutation, Cancer research, biology.protein, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a277e2cabf966445372f837b9fc33b98Test
http://europepmc.org/articles/PMC8177776Test

2

Clinical influence of switching companion diagnostic tests for EGFR‐TKs from Therascreen to Cobas v2

المؤلفون: Ryo Ariyasu, Hiroshi Yoshida, Hiroaki Sakamoto, Satoru Kitazono, Natsuki Takano, Makoto Nishio, Ryosuke Tsugitomi, Yoshiaki Amino, Ryo Manabe, Ken Uchibori, Shinsuke Ogusu, Noriko Yanagitani, Takehiro Tozuka

المصدر: Thoracic Cancer, Vol 12, Iss 6, Pp 906-913 (2021)
Thoracic Cancer

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, Future studies, next‐generation sequencing (NGS), lcsh:RC254-282, Young Adult, 03 medical and health sciences, T790M, 0302 clinical medicine, Internal medicine, medicine, Humans, Osimertinib, In patient, Lung cancer, Protein Kinase Inhibitors, EGFR‐TKI, Aged, Aged, 80 and over, Diagnostic Tests, Routine, business.industry, Cancer, Original Articles, General Medicine, Middle Aged, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, ErbB Receptors, Companion diagnostic (CDx), 030104 developmental biology, Egfr mutation, 030220 oncology & carcinogenesis, polymerase chain reaction (PCR), Original Article, Female, EGFR mutation, business, Companion diagnostic

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b4b8e6ae7a1f05a33f62f905a01ce39Test
https://doi.org/10.1111/1759-7714.13797Test

3

Poor efficacy of anti‐programmed cell death‐1/ligand 1 monotherapy for non‐small cell lung cancer patients with active brain metastases

المؤلفون: Tsukasa Hasegawa, Ryo Ariyasu, Masahiro Seike, Makoto Nishio, Takeshi Horai, Hiroshi Yoshida, Noriko Yanagitani, Akihiko Gemma, Ken Uchibori, Takehiro Tozuka, Satoru Kitazono, Yoshiaki Amino, Takahiro Yoshizawa, Hiroaki Sakamoto, Shinya Uematsu

المصدر: Thoracic Cancer
Thoracic Cancer, Vol 11, Iss 9, Pp 2465-2472 (2020)

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Lung Neoplasms, medicine.medical_treatment, immune checkpoint inhibitor, B7-H1 Antigen, central nervous system metastases, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, brain metastases, Programmed cell death 1, Medicine, Aged, 80 and over, biology, Brain Neoplasms, digestive, oral, and skin physiology, General Medicine, Middle Aged, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, 030220 oncology & carcinogenesis, Female, Original Article, Non small cell, medicine.symptom, Antibody, Adult, Pulmonary and Respiratory Medicine, medicine.medical_specialty, education, lcsh:RC254-282, Anti PD‐1/PD‐L1 antibody, Asymptomatic, 03 medical and health sciences, Internal medicine, Humans, Poor performance status, Lung cancer, Aged, Retrospective Studies, business.industry, Retrospective cohort study, Original Articles, Immunotherapy, medicine.disease, stomatognathic diseases, 030104 developmental biology, biology.protein, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8f1ff75d1a1081b9e457351f91678f9Test
https://doi.org/10.1111/1759-7714.13557Test

4

Characteristics of central nervous system progression in non‐small cell lung cancer treated with crizotinib or alectinib

المؤلفون: Yoshiaki Amino, Ken Uchibori, Hiroaki Sakamoto, Sadatomo Tasaka, Makoto Nishio, Hiroshi Yoshida, Ryo Manabe, Shinsuke Ogusu, Noriko Yanagitani, Satoru Kitazono, Takehiro Tozuka, Ryosuke Tsugitomi, Ryo Ariyasu

المصدر: Cancer Reports
Cancer Reports, Vol 4, Iss 6, Pp n/a-n/a (2021)

مصطلحات موضوعية: non‐small cell lung cancer, Adult, Male, Alectinib, Oncology, Cancer Research, medicine.medical_specialty, Lung Neoplasms, medicine.medical_treatment, Carbazoles, Radiosurgery, Metastasis, Central Nervous System Neoplasms, Young Adult, Crizotinib, Piperidines, Carcinoma, Non-Small-Cell Lung, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Anaplastic lymphoma kinase, alectinib, Anaplastic Lymphoma Kinase, Lung cancer, RC254-282, Aged, Retrospective Studies, Aged, 80 and over, medicine.diagnostic_test, business.industry, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Magnetic resonance imaging, Original Articles, Middle Aged, Prognosis, medicine.disease, Survival Rate, Tumor progression, CNS metastases, Original Article, Female, Neoplasm Recurrence, Local, business, Follow-Up Studies, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bb6c788d452006c53dc1e773de93841Test
https://doi.org/10.1002/cnr2.1414Test

5

Dissociated responses at initial computed tomography evaluation is a good prognostic factor in non-small cell lung cancer patients treated with anti-programmed cell death-1/ligand 1 inhibitors

المؤلفون: Akihiko Gemma, Ken Uchibori, Takeshi Horai, Takehiro Tozuka, Masahiro Seike, Atsushi Horiike, Noriko Yanagitani, Hiroshi Yoshida, Yoshiaki Amino, Makoto Nishio, Takahiro Yoshizawa, Hiroaki Sakamoto, Shinya Uematsu, Satoru Kitazono, Tsukasa Hasegawa

المصدر: BMC Cancer
BMC Cancer, Vol 20, Iss 1, Pp 1-8 (2020)

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Antibodies, Monoclonal, Humanized, lcsh:RC254-282, Gastroenterology, Immune checkpoint inhibitors, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, Non-small cell lung cancer, Surgical oncology, Carcinoma, Non-Small-Cell Lung, Internal medicine, Genetics, medicine, Humans, Lung cancer, Aged, Retrospective Studies, Aged, 80 and over, Proportional hazards model, business.industry, Hazard ratio, Cancer, Retrospective cohort study, Middle Aged, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Prognosis, medicine.disease, Survival Analysis, Confidence interval, Nivolumab, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Female, Dissociated responses, Tomography, X-Ray Computed, business, Progressive disease, Research Article

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c8ac12f5bf9eb83b622738fcd3ddd93Test
https://doi.org/10.1186/s12885-020-6704-zTest

6

Association of High Neutrophil-to-Lymphocyte Ratio With Poor Outcomes of Pembrolizumab Therapy in High-PD-L1-expressing Non-small Cell Lung Cancer

المؤلفون: Hiroshi Yoshida, Ken Uchibori, Noriko Yanagitani, Kazuyoshi Kuwano, Hirofumi Utsumi, Makoto Nishio, Yoshiaki Amino, Takahiro Yoshizawa, Takehiro Tozuka, Takeshi Horai, Hiroaki Sakamoto, Hiroshi Wakui, Shinya Uematsu, Tsukasa Hasegawa, Satoru Kitazono, Atsushi Horiike

المصدر: Anticancer research. 39(12)

مصطلحات موضوعية: Oncology, Adult, Male, Cancer Research, medicine.medical_specialty, Multivariate analysis, Lung Neoplasms, Pembrolizumab, Antibodies, Monoclonal, Humanized, B7-H1 Antigen, 03 medical and health sciences, Leukocyte Count, 0302 clinical medicine, Antineoplastic Agents, Immunological, Internal medicine, PD-L1, Carcinoma, Non-Small-Cell Lung, medicine, Humans, In patient, Lymphocyte Count, Stage (cooking), Neutrophil to lymphocyte ratio, Lung cancer, Aged, Retrospective Studies, Aged, 80 and over, biology, business.industry, General Medicine, Middle Aged, medicine.disease, Prognosis, Survival Analysis, Up-Regulation, Treatment Outcome, 030220 oncology & carcinogenesis, biology.protein, Female, Non small cell, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b26358c999a6704ef23e62ffc93cc6fTest
https://pubmed.ncbi.nlm.nih.gov/31810952Test

7

Safety and efficacy of nivolumab and standard chemotherapy drug combination in patients with advanced non-small-cell lung cancer: a four arms phase Ib study

المؤلفون: Kuniko Sunami, Noboru Yamamoto, E. Kubo, Hidehito Horinouchi, Yutaka Fujiwara, Satoru Kitazono, Hiroshi Nokihara, Ayako Tanaka, Hirofumi Utsumi, Hidenori Mizugaki, Shintaro Kanda, Tomohide Tamura, K. Goto, H. Hozumi, Hideaki Shiraishi

المصدر: Annals of Oncology

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, medicine.medical_treatment, Docetaxel, chemotherapy, Deoxycytidine, Carboplatin, chemistry.chemical_compound, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, Antibodies, Monoclonal, Hematology, Middle Aged, Bevacizumab, Pemetrexed, 030220 oncology & carcinogenesis, Female, Taxoids, Nivolumab, medicine.drug, Adult, medicine.medical_specialty, Thoracic Tumors, Paclitaxel, Disease-Free Survival, 03 medical and health sciences, Internal medicine, medicine, Humans, Lung cancer, Aged, Neoplasm Staging, nivolumab, combination, Chemotherapy, business.industry, Original Articles, medicine.disease, Gemcitabine, 030104 developmental biology, non-small-cell lung cancer, chemistry, Cisplatin, Neoplasm Recurrence, Local, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d729685d9985978720978ae7ed00f0c0Test
https://doi.org/10.1093/annonc/mdw416Test

8

Phase Ia/Ib study of the pan-class I PI3K inhibitor pictilisib (GDC-0941) administered as a single agent in Japanese patients with solid tumors and in combination in Japanese patients with non-squamous non-small cell lung cancer

المؤلفون: Yutaka Fujiwara, Atsushi Horiike, Michiyasu Inatani, Satoru Kitazono, Yuko Tanabe, Noboru Yamamoto, Noriko Yanagitani, Shunsuke Kondo, Kenji Tamura, Jun Tanaka, Makoto Nishio, Satoru Iwasa

المصدر: Investigational New Drugs. 35:37-46

مصطلحات موضوعية: Male, 0301 basic medicine, medicine.medical_specialty, Indazoles, Maximum Tolerated Dose, Paclitaxel, Bevacizumab, Antineoplastic Agents, Gastroenterology, Carboplatin, 03 medical and health sciences, 0302 clinical medicine, Asian People, Pharmacokinetics, Neoplasms, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Maculopapular rash, medicine, Humans, Pharmacology (medical), Phosphorylation, Lung cancer, Aged, Phosphoinositide-3 Kinase Inhibitors, Pharmacology, Sulfonamides, business.industry, Area under the curve, Middle Aged, medicine.disease, Surgery, Treatment Outcome, 030104 developmental biology, Oncology, Tolerability, 030220 oncology & carcinogenesis, Pharmacodynamics, Female, medicine.symptom, business, Proto-Oncogene Proteins c-akt, Febrile neutropenia, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f507e3d32f48d053d95cc7bad1004e6Test
https://doi.org/10.1007/s10637-016-0382-3Test

9

Barcode sequencing identifies resistant mechanisms to epidermal growth factor receptor inhibitors in circulating tumor DNA of lung cancer patients

المؤلفون: Tomoaki Sonoda, Yosuke Dotsu, Junji Koyama, Kazuko Sakai, Takahiro Yoshizawa, Makoto Nishio, Noriko Yanagitani, Shingo Nishikawa, Atsushi Horiike, Satoru Kitazono, Kazuto Nishio, Ken Uchibori, Masafumi Saiki, Ryo Ariyasu

المصدر: Cancer Science

مصطلحات موضوعية: 0301 basic medicine, Male, non‐small cell lung cancer, Cancer Research, Lung Neoplasms, DNA Copy Number Variations, molecular barcode sequencing, Biology, medicine.disease_cause, droplet digital PCR, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Germline mutation, Carcinoma, Non-Small-Cell Lung, medicine, Humans, Digital polymerase chain reaction, Epidermal growth factor receptor, Lung cancer, Gene, Protein Kinase Inhibitors, Genetics, Genomics, and Proteomics, Aged, Neoplasm Staging, circulating tumor DNA, High-Throughput Nucleotide Sequencing, General Medicine, Sequence Analysis, DNA, Original Articles, Middle Aged, Proto-Oncogene Proteins c-met, Resistance mutation, medicine.disease, Molecular biology, respiratory tract diseases, ErbB Receptors, 030104 developmental biology, Oncology, chemistry, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, biology.protein, Female, Original Article, KRAS, epidermal growth factor receptor, DNA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a45ab0fb84150f7169c30ba828b2daa5Test
https://pubmed.ncbi.nlm.nih.gov/31361375Test

10

Improvement in the survival of patients with stage IV non-small-cell lung cancer: Experience in a single institutional 1995-2017

المؤلفون: Akihiko Gemma, Ken Uchibori, Atsushi Horiike, Tomoaki Sonoda, Shingo Nishikawa, Makoto Nishio, Kakeru Hisakane, Yosuke Kawashima, Masafumi Saiki, Noriko Yanagitani, Fumiyoshi Ohyanagi, Ryo Ariyasu, Satoru Kitazono, Junji Koyama, Tomoyo Oguri, Natsuki Takano

المصدر: Lung cancer (Amsterdam, Netherlands). 131

مصطلحات موضوعية: 0301 basic medicine, Pulmonary and Respiratory Medicine, Oncology, Adult, Male, Cancer Research, medicine.medical_specialty, Lung Neoplasms, medicine.medical_treatment, Antineoplastic Agents, Stage IV non-small cell lung cancer, Disease-Free Survival, Fusion gene, 03 medical and health sciences, Young Adult, 0302 clinical medicine, Japan, Internal medicine, Carcinoma, Non-Small-Cell Lung, Medicine, Anaplastic lymphoma kinase, Humans, Epidermal growth factor receptor, Lung cancer, Aged, Neoplasm Staging, Aged, 80 and over, Chemotherapy, biology, business.industry, Cancer, Middle Aged, medicine.disease, Survival Analysis, 030104 developmental biology, 030220 oncology & carcinogenesis, Propensity score matching, biology.protein, Female, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8835e9c6aa5e89ac5ae2bb431b8fa5dbTest
https://pubmed.ncbi.nlm.nih.gov/31027701Test

تنقيح النتائج